Proceedings of the World Molecular Imaging Congress 2015, Honolulu, Hawaii, September 2-5, 2015: General Abstracts.

Abstract

INTRODUCTION: As opposed to the routine use of nanomedicines for drug targeting to solid tumors, the highest medical need refers to targeting and treating metastasis. Little is known regarding the accumulation of polymers, liposomes and micelles in metastases, and no systematic analyses have been performed comparing drug targeting to different types (and sizes) of metastases. We here employ three different nanocarriers, an optically imageable metastatic mouse model and several different imaging techniques, to assess drug targeting and drug treatment of metastasis. With fluorophore-labeled nanomedicines, we show that metastases can be more efficiently targeted than primary tumors. In addition, we provide convincing proof-of-principle that docetaxel-loaded micelles are able to inhibit metastasis, also providing initial insights into the vascularity of different types of metastases within different organs. METHODS: Female Nu/Nu mice were orthotopically implanted with 2x105 4T1-iRFP cells (exc 680 nm). Mice were non-invasively monitored for local tumor growth and metastatic colonization using hybrid 3D computed tomography - fluorescence molecular tomography (CT-FMT). Upon metastastic detection, fluorophore-labeled (488/750) polymers, liposomes and micelles were i.v. injected. At 72h, primary tumors and metastases were harvested for ex vivo fluorescence reflectance imaging (2D FRI), assessing the colocalization between metastases (680nm) and nanocarriers (750nm). In an initial therapy study, 4T1-iRFP bearing mice were i.v. treated with vehicle, free docetaxel (Taxotere 30 mg/kg), and core-crosslinked polymeric micelles containing docetaxel (CriPec 30 mg/kg). In addition, a single CriPec 90 mg/kg was administered. Animals were CT-FMT scanned for metastasis colonization, organs were harvested for histology and 1 mouse/group was perfused with the vascular casting agent Microfil (for high-resolution ex vivo CT imaging of blood vessels in tumors and metastases). RESULTS AND DISCUSSION: Metastatic colonization was sensitively detected using CT-FMT (Fig.1A-C). Fluorophore-labeled polymers and liposomes efficiently colocalized with metastases (overlap between 680 and 750 signals, Fig.1B-C), with no accumulation in healthy areas in lungs, lymph nodes and ovary (Fig.1C). The therapeutic efficacy of docetaxel-loaded core-crosslinked polymeric micelles was found to be higher than that of the free drug, with smaller primary tumors and less lung metastases, as visualized and quantified using optical imaging, CT imaging and histology (Fig.1D-E). A single 90 mg/kg micelle dose was found to be more efficient than three 30 mg/kg doses of free drug. High-resolution ex vivo μCT provided initial insights on the microvascular network in different types of metastases, showing that those are more extensively and more homogenously vascularized than primary tumors (Fig.1F). CONCLUSION: In summary, we here systematically show that different types of metastases - in particular lung, lymph node, bone and ovary - can be efficiently targeted and treated using nanomedicines. Initial evidence correlating vascular characteristics with metastatic drug targeting is also provided. (Figure Presented).